When the Centers for Disease Control and Prevention (CDC) released its 2022 STI surveillance report, it was far from a clean ...

There is an expectation that other providers will pick up the slack and take care of Medicaid-insured patients currently ...

COVID paused prevention efforts, which helped fuel the rise in new infections. Now federal funding cuts threaten to disrupt those efforts again.

Basilea already secured $29 million to develop its antifungals fosmanogepix and BAL2062, and the Swiss company announced this morning that it has confirmed it will also receive its next tranche of $39 ...